dietary interventions for the patient with gastropathy l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Dietary Interventions for the Patient with Gastropathy PowerPoint Presentation
Download Presentation
Dietary Interventions for the Patient with Gastropathy

Loading in 2 Seconds...

play fullscreen
1 / 44

Dietary Interventions for the Patient with Gastropathy - PowerPoint PPT Presentation


  • 168 Views
  • Uploaded on

Dietary Interventions for the Patient with Gastropathy. Julianne Steiner, MS, RD, CDE Endocrine/Diabetes Clinic McKay-Dee Hospital Center. Objectives. The participant will be able to: 1. Describe neuropathic complications of diabetes that can impact the GI tract.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Dietary Interventions for the Patient with Gastropathy' - huela


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
dietary interventions for the patient with gastropathy

Dietary Interventions for the Patient with Gastropathy

Julianne Steiner, MS, RD, CDE

Endocrine/Diabetes Clinic

McKay-Dee Hospital Center

objectives
Objectives

The participant will be able to:

1. Describe neuropathic complications of diabetes that can impact the GI tract.

2. Describe nutritional therapies that can be utilized in treating diabetic gastropathy.

normal gastric function
Normal Gastric Function
  • Fundic relaxation to accommodate food
  • Contractions for breaking large food particles
  • Pyloric relaxation to allow food to exit
normal gastric emptying
Normal Gastric Emptying
  • Coordinated effort between different regions of the stomach and the duodenum
  • Extrinsic modulation by CNS and distal gut factors
    • “Pacemaker” located on upper, outer portion of stomach. Electrical waves cause muscles to contract.
    • Normally contracts 3 X/min.
    • Stomach empties in 90-120 minutes after eating
gastric emptying rate
Gastric Emptying Rate
  • Physical nature of food
    • Liquid vs. solid
  • Particle size
    • 2 mm in diameter
  • Fat content
  • Caloric content
    • High calorie liquids empty at a constant rate
gastroparesis
Gastroparesis
  • Characterized by delayed gastric emptying in the absence of mechanical obstruction
  • Vagal nerve conduction is diminished
  • Reduced smooth muscle contractility
  • Compromised myoelectrical activity
  • Results in erratic blood glucose control
gastroparesis7
Gastroparesis
  • Estimated that up to 75% of individuals with diabetes develop some gastrointestinal symptoms
  • Many patients do not report symptoms to doctor
  • Patients do not realize that symptoms are related to diabetes.
gastroparesis8
Gastroparesis
  • Symptoms can last days to months or occur in cycles
  • Poor correlation between symptoms and actual diagnosis
  • Little evidence of a time interval between diabetes diagnosis and development of gastroparesis
gastroparesis9
Gastroparesis
  • 11%- 18% of individuals with diabetes report symptoms
  • 25%-50% of patients with Type 1 diabetes (not correlated with nongastrointestinal complications)
  • About 30%of patients with Type 2 diabetes
gastroparesis10
Gastroparesis
  • majority of patients are women (82%)
  • Associated with increased BMI
  • Not universal or inevitable
pittsburgh epidemiology of diabetes complications
Pittsburgh Epidemiology of Diabetes Complications

A: Proliferative retinopathy, B: Overt nephropathy,

C: Symptomatic automatic neuropathy, D: Distal symmetric polyneuropathy

Pambianco, G., et al. The 30 –Year Natural History of Type 1 Diabetes Complications

Diabetes 55:1463-1469, 2006

clinical consequences
Clinical Consequences
  • Gastrointestinal symptoms
  • Alteration in oral drug absorption
    • Glipizide
  • Poor glycemic control
symptoms nonspecific
Symptoms (nonspecific)
  • Nausea (92%)
  • Vomiting (84%)
  • Bloating (75%)
  • Early satiety
  • Upper abdominal discomfort
  • Reflux
  • Unexplained weight loss
  • Erratic blood glucose levels
delayed gastric emptying
Delayed Gastric Emptying
  • First sign: erratic blood glucose levels
  • Other symptoms may be mild to severe
  • Unexplained weight loss
  • Prone to bezoar formation / obstruction
blood glucose effects
Blood Glucose Effects
  • Hyperglycemia slows gastric emptying
    • Causes pyloric value to contract
    • Decreases motility
    • Induces gastric dysrhythmias
blood glucose effects17
Blood Glucose Effects
  • Hyperglycemia slows gastric emptying
    • Causes pyloric value to contract
    • decreases motility
  • Hypoglycemia accelerates gastric emptying
    • Important in counter-regulation of hypoglycemia

Continuous inverse relationship between blood glucose levels and rate of gastric emptying.

pathogenesis
Pathogenesis
  • Combination of factors
    • Vagal neuropathy
    • Hyperglycemia
    • Unknown factors
diagnosis
Diagnosis
  • Consider medications that may cause gastric stasis:
    • Anticholinergic agents
    • Antidepressants
    • Calcium-channel blockers
  • Upper endoscopy to rule out obstruction
diagnosis20
Diagnosis
  • Scintigraphy (gold standard)
    • Calculates time to empty 50% of meal and percentage remaining after 2 and 4 hours
  • Isotope breath tests
    • Measures amount of CO2 in breath samples
  • Ultrasonography
    • Measures flow of food through pyloric sphincter
  • Magnetic resonance imaging
nutrition management
Nutrition Management
  • Treatment goals:
    • Alleviate symptoms
    • Improve gastric emptying
    • Enhance glycemic control
    • Delay progression of other complications
gastroparesis22
Gastroparesis
  • Emptying of solid food is delayed
  • Emptying of liquids remains unchanged until condition becomes more advanced
  • Prone to development of bezoars
  • Severity of symptoms does not correlate with degree of gastric emptying.
nutrition management23
Nutrition Management
  • Eat smaller meals more frequently.
  • Eat low-fiber forms of high-fiber foods, such as well-cooked fruits and vegetables rather than raw fruits and vegetables.
  • Choose mostly low-fat foods, add small servings of higher fat foods if tolerated
  • Avoid fibrous fruits and vegetables, such as oranges and broccoli, that are likely to cause bezoars.
nutrition management24
Nutrition Management
  • Choose soft or liquid foods such as soups and pureed foods
  • Drink water throughout each meal.
  • Try mild exercise after eating, such as going for a walk.
  • Individualize to patient’s tolerance based on postprandial glucose results
nutrition management25
Nutrition Management
  • Avoid alcohol and tobacco
  • Chew sugar-free gum for 1 hr after meal
nutrition management26
Nutrition Management
  • Add nutrition supplements
  • High nutrient liquids
  • Enteral feedings via jejunostomy tube
  • TPN – seldom indicated
case study
Case Study

“Carol”

2/3/2011

  • 52 yo female
  • Type 1
  • Ht: 62”
  • Wt: 140 (down 3 lbs. in 3 mo.)
  • A1c 7.3
  • Blood glucose: 150-200
  • High BG spikes after meal
  • Eats one meal a day
  • Gives bolus after eating

Counseled on diet for gastroparesis:

-6 small meals

- low fat, fiber

-avoid carbonation and gas producing foods

-Advised to give part of bolus before meal

case study28
Case Study

“Carol”

  • 7/19/11
  • Wt: 141 ( up 1 pound)
  • A1c (7/19/11): 6.8 (down 0.5)
  • Blood glucose: majority within target range on cgms
  • Tries to eat something for breakfast and lunch, but still skips meals
  • ?? Nutrition adequacy
dietary adequacy
Dietary Adequacy
  • 10 Type 1 patients
  • Mean age 44 yrs
  • BMI 25.4
  • A1c 10.4
  • Common symptoms
    • Bloating, nausea, halitosis, acid reflux, belching, abdominal pain, flatulence, diarrhea, anorexia, heartburn, vomiting
    • Symptom severity did not correlate with A1c

Goldberg K.B. JADA 97:420-422, 1997.

dietary adequacy30
Dietary Adequacy
  • Mean energy intake: 63% of recommended levels
  • Carbohydrate and fat reduced proportionately more than protein
  • Calcium: 70% of recommended amount
  • Recommend nutrition supplements to this population

Goldberg K.B. JADA 97:420-422, 1997.

nutrition management31
Nutrition Management
  • Factors which influence postprandial glucose
    • Fasting blood glucose level
    • Meal composition (carbohydrate)
    • Rate of absorption from small intestine
    • Insulin secretion/timing
    • Hepatic glucose metabolism
    • Peripheral insulin sensitivity
insulin therapy
Insulin Therapy
  • Mismatch between insulin action and glucose absorption from meal
  • Insulin peaks before glucose is absorbed
  • Causes early hypoglycemia
  • Later, glucose is absorbed, but no insulin
  • Causes late hyperglycemia
insulin treatment strategies
Insulin Treatment Strategies
  • Rapid acting- adjust timing of injection
  • Regular insulin before meal
  • Delayed or extended bolus delivery with pump
  • Monitor blood glucose frequently or use CGMS
pharmacotherapy
Pharmacotherapy
  • Metoclopramide (Reglan)
    • Stimulates stomach muscle contractions
    • Helps reduce nausea and vomiting
    • Taken 20-30 minutes before meals and at bedtime
    • Long-term use is limited by development of:
      • Tolerance
      • Restlessness
      • prolactinemia
pharmacotherapy35
Pharmacotherapy
  • Erythromycin
    • Increases stomach contractions
    • Given IV in acutely ill
    • Less effective when given orally or long term
    • ? transdermally
pharmacotherapy36
Pharmacotherapy
  • Botulinum toxin (Botox)
    • Intrapyloric injection
    • Relaxes pyloric muscle in some
    • Benefits are temporary
      • No efficacy in controlled studies
pharmacotherapy37
Pharmacotherapy
  • Domperidone (Motilium)
    • Used to suppress nausea/vomiting
    • Used as a prokinetic
    • Stimulates lactation

*Not approved for use in the U. S.

electrical gastric stimulation
Electrical Gastric Stimulation
  • Uses electrical current to cause stomach contractions
  • Surgically placed in a pocket on outer edge of stomach
enterra therapy
Enterra Therapy
  • Pacemaker-like device
  • Produced by Medtronic
  • Battery operated (battery life 5-10 yrs)
  • Implanted in abdomen
  • Electrode connected to the stomach muscle
  • Releases low-voltage electrical shocks every 6 seconds, causing stomach to contract
medtronic enterra
Medtronic Enterra
  • 2.2” X 2.4” X 0.4”
enterra therapy41
Enterra Therapy
  • Approved by U.S. FDA April, 2000 as humanitarian device Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology. The effectiveness of this device for this use has not been demonstrated.
  • Because of the HDE status, the system must be implanted in a medical center whose institutional review board (IRB) has approved use of the device.
surgical treatment
Surgical Treatment
  • Rarely used
  • Increase the size of opening between stomach and intestine
  • Gastrectomy
long term management
Long-term Management
  • Multidisciplinary approach
  • Patient’s understanding of how food and medicines work together
  • Frequent blood glucose monitoring (4-8 /day) and/or use of CGMS
  • Individualized diet according to patient tolerance
  • Normal life expectancy after adjustments for other disorders